Nomograms for Prognostication of Outcome in Patients with Esophageal and Gastroesophageal Carcinoma Undergoing Definitive Chemoradiotherapy

Effect of preoperative concurrent chemoradiotherapy on survival of patients with resectable esophageal or esophagogastric junction cancer: Results from a multicenter randomized phase III study.

(2017) A. V. Gaast et al.   JOURNAL OF CLINICAL ONCOLOGY

Esophageal and Esophagogastric Junction Cancers

(2017) Jaffer A. Ajani et al.   Journal of the National Comprehensive Cancer Network

Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapy

(2011) Akihiro Suzuki et al.   CANCER

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

The clinical application of18F-fluorodeoxyglucose positron emission tomography to predict survival in patients with operable esophageal cancer

(2009) Hiroyuki Kato et al.   CANCER

Incidence of Adenocarcinoma of the Esophagus Among White Americans by Sex, Stage, and Age

(2008) L. M. Brown et al.   JNCI-Journal of the National Cancer Institute